487 related articles for article (PubMed ID: 15472217)
1. Role of hexosamines in insulin resistance and nutrient sensing in human adipose and muscle tissue.
Pouwels MJ; Tack CJ; Span PN; Olthaar AJ; Sweep CG; Huvers FC; Lutterman JA; Hermus AR
J Clin Endocrinol Metab; 2004 Oct; 89(10):5132-7. PubMed ID: 15472217
[TBL] [Abstract][Full Text] [Related]
2. Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes.
Pouwels MJ; Span PN; Tack CJ; Olthaar AJ; Sweep CG; van Engelen BG; de Jong JG; Lutterman JA; Hermus AR
J Clin Endocrinol Metab; 2002 Nov; 87(11):5179-84. PubMed ID: 12414889
[TBL] [Abstract][Full Text] [Related]
3. Role of the glucosamine pathway in fat-induced insulin resistance.
Hawkins M; Barzilai N; Liu R; Hu M; Chen W; Rossetti L
J Clin Invest; 1997 May; 99(9):2173-82. PubMed ID: 9151789
[TBL] [Abstract][Full Text] [Related]
4. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.
Hazel M; Cooksey RC; Jones D; Parker G; Neidigh JL; Witherbee B; Gulve EA; McClain DA
Endocrinology; 2004 May; 145(5):2118-28. PubMed ID: 14684615
[TBL] [Abstract][Full Text] [Related]
5. Hexosamines are unlikely to function as a nutrient-sensor in 3T3-L1 adipocytes: a comparison of UDP-hexosamine levels after increased glucose flux and glucosamine treatment.
Bosch RR; Pouwels MJ; Span PN; Olthaar AJ; Tack CJ; Hermus AR; Sweep CG
Endocrine; 2004 Feb; 23(1):17-24. PubMed ID: 15034192
[TBL] [Abstract][Full Text] [Related]
6. Exploring levels of hexosamine biosynthesis pathway intermediates and protein kinase C isoforms in muscle and fat tissue of Zucker Diabetic Fatty rats.
Bosch RR; Janssen SW; Span PN; Olthaar A; van Emst-de Vries SE; Willems PH; Martens J M G; Hermus AR; Sweep CC
Endocrine; 2003 Apr; 20(3):247-52. PubMed ID: 12721503
[TBL] [Abstract][Full Text] [Related]
7. Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice.
Buse MG; Robinson KA; Gettys TW; McMahon EG; Gulve EA
Am J Physiol; 1997 Jun; 272(6 Pt 1):E1080-8. PubMed ID: 9227455
[TBL] [Abstract][Full Text] [Related]
8. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat.
Wang J; Liu R; Hawkins M; Barzilai N; Rossetti L
Nature; 1998 Jun; 393(6686):684-8. PubMed ID: 9641678
[TBL] [Abstract][Full Text] [Related]
9. Hexosamines regulate leptin production in human subcutaneous adipocytes.
Considine RV; Cooksey RC; Williams LB; Fawcett RL; Zhang P; Ambrosius WT; Whitfield RM; Jones R; Inman M; Huse J; McClain DA
J Clin Endocrinol Metab; 2000 Oct; 85(10):3551-6. PubMed ID: 11061500
[TBL] [Abstract][Full Text] [Related]
10. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
11. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
12. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver.
Robinson KA; Weinstein ML; Lindenmayer GE; Buse MG
Diabetes; 1995 Dec; 44(12):1438-46. PubMed ID: 7589852
[TBL] [Abstract][Full Text] [Related]
13. Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid.
McClain DA; Hazel M; Parker G; Cooksey RC
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E973-9. PubMed ID: 15613679
[TBL] [Abstract][Full Text] [Related]
14. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia.
McClain DA; Lubas WA; Cooksey RC; Hazel M; Parker GJ; Love DC; Hanover JA
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10695-9. PubMed ID: 12136128
[TBL] [Abstract][Full Text] [Related]
15. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
[TBL] [Abstract][Full Text] [Related]
16. Increased hexosamine pathway flux and high fat feeding are not additive in inducing insulin resistance: evidence for a shared pathway.
Cooksey RC; McClain DA
Amino Acids; 2011 Mar; 40(3):841-6. PubMed ID: 20658157
[TBL] [Abstract][Full Text] [Related]
17. UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues.
Yki-Järvinen H; Vogt C; Iozzo P; Pipek R; Daniels MC; Virkamäki A; Mäkimattila S; Mandarino L; DeFronzo RA; McClain D; Gottschalk WK
Diabetologia; 1997 Jan; 40(1):76-81. PubMed ID: 9028721
[TBL] [Abstract][Full Text] [Related]
18. Hexosamines stimulate leptin production in transgenic mice.
McClain DA; Alexander T; Cooksey RC; Considine RV
Endocrinology; 2000 Jun; 141(6):1999-2002. PubMed ID: 10830282
[TBL] [Abstract][Full Text] [Related]
19. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues.
Virkamäki A; Daniels MC; Hämäläinen S; Utriainen T; McClain D; Yki-Järvinen H
Endocrinology; 1997 Jun; 138(6):2501-7. PubMed ID: 9165041
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice overexpressing the rate-limiting enzyme for hexosamine synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance.
Cooksey RC; McClain DA
Ann N Y Acad Sci; 2002 Jun; 967():102-11. PubMed ID: 12079840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
